Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089578413> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W3089578413 endingPage "658" @default.
- W3089578413 startingPage "651" @default.
- W3089578413 abstract "At the end of December 2019, a new strain of coronavirus was identified in the Wuhan city of Hubei province in China. Within a shorter period of time, an unprecedented outbreak of this strain was witnessed over the entire Wuhan city. This novel coronavirus strain was later officially renamed as COVID-19 (Coronavirus disease 2019) by the World Health Organization. The mode of transmission was human-to-human contact and hence resulted in a rapid surge across the globe where more than 24 million people have been infected with COVID-19. In the current scenario, finding potent drug candidates for the treatment of COVID-19 has emerged as the most challenging task for clinicians and researchers worldwide. Identification of new drugs and vaccine development may take from a few months to years based on the clinical trial processes. To overcome the several limitations involved in identifying and bringing out potent drug candidates for treating COVID-19, in the present study attempts were made to screen the FDA approved drugs using High Throughput Virtual Screening (HTVS). The COVID-19 main protease (COVID-19 Mpro) was chosen as the drug target for which the FDA approved drugs were initially screened with HTVS. The drug candidates that exhibited favorable docking score, energy, and emodel calculations were further taken for performing Induced Fit Docking (IFD) using Schrodinger's GLIDE. From the flexible docking results, the following four FDA approved drugs Sincalide, Pentagastrin, Ritonavir, and Phytonadione were identified. In particular, Sincalide and Pentagastrin can be considered potential key players for the treatment of COVID-19 disease." @default.
- W3089578413 created "2020-10-08" @default.
- W3089578413 creator A5003730282 @default.
- W3089578413 creator A5077113784 @default.
- W3089578413 date "2020-09-28" @default.
- W3089578413 modified "2023-10-05" @default.
- W3089578413 title "Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease" @default.
- W3089578413 cites W2006012833 @default.
- W3089578413 cites W2044921755 @default.
- W3089578413 cites W2067681225 @default.
- W3089578413 cites W2097964743 @default.
- W3089578413 cites W2109765467 @default.
- W3089578413 cites W2132629607 @default.
- W3089578413 cites W2141693585 @default.
- W3089578413 cites W2155523942 @default.
- W3089578413 cites W3002022896 @default.
- W3089578413 cites W3003322996 @default.
- W3089578413 cites W3003465021 @default.
- W3089578413 cites W3004280078 @default.
- W3089578413 cites W3005300812 @default.
- W3089578413 cites W3005473082 @default.
- W3089578413 cites W3007223608 @default.
- W3089578413 cites W3008447280 @default.
- W3089578413 cites W3015608194 @default.
- W3089578413 doi "https://doi.org/10.1007/s10989-020-10115-6" @default.
- W3089578413 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7521772" @default.
- W3089578413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33013255" @default.
- W3089578413 hasPublicationYear "2020" @default.
- W3089578413 type Work @default.
- W3089578413 sameAs 3089578413 @default.
- W3089578413 citedByCount "12" @default.
- W3089578413 countsByYear W30895784132020 @default.
- W3089578413 countsByYear W30895784132021 @default.
- W3089578413 countsByYear W30895784132022 @default.
- W3089578413 countsByYear W30895784132023 @default.
- W3089578413 crossrefType "journal-article" @default.
- W3089578413 hasAuthorship W3089578413A5003730282 @default.
- W3089578413 hasAuthorship W3089578413A5077113784 @default.
- W3089578413 hasBestOaLocation W30895784131 @default.
- W3089578413 hasConcept C126322002 @default.
- W3089578413 hasConcept C142462285 @default.
- W3089578413 hasConcept C159047783 @default.
- W3089578413 hasConcept C2522874641 @default.
- W3089578413 hasConcept C2777648638 @default.
- W3089578413 hasConcept C2779134260 @default.
- W3089578413 hasConcept C2779298103 @default.
- W3089578413 hasConcept C2780035454 @default.
- W3089578413 hasConcept C2993143319 @default.
- W3089578413 hasConcept C3007834351 @default.
- W3089578413 hasConcept C3008058167 @default.
- W3089578413 hasConcept C524204448 @default.
- W3089578413 hasConcept C71924100 @default.
- W3089578413 hasConcept C89623803 @default.
- W3089578413 hasConcept C98274493 @default.
- W3089578413 hasConceptScore W3089578413C126322002 @default.
- W3089578413 hasConceptScore W3089578413C142462285 @default.
- W3089578413 hasConceptScore W3089578413C159047783 @default.
- W3089578413 hasConceptScore W3089578413C2522874641 @default.
- W3089578413 hasConceptScore W3089578413C2777648638 @default.
- W3089578413 hasConceptScore W3089578413C2779134260 @default.
- W3089578413 hasConceptScore W3089578413C2779298103 @default.
- W3089578413 hasConceptScore W3089578413C2780035454 @default.
- W3089578413 hasConceptScore W3089578413C2993143319 @default.
- W3089578413 hasConceptScore W3089578413C3007834351 @default.
- W3089578413 hasConceptScore W3089578413C3008058167 @default.
- W3089578413 hasConceptScore W3089578413C524204448 @default.
- W3089578413 hasConceptScore W3089578413C71924100 @default.
- W3089578413 hasConceptScore W3089578413C89623803 @default.
- W3089578413 hasConceptScore W3089578413C98274493 @default.
- W3089578413 hasIssue "1" @default.
- W3089578413 hasLocation W30895784131 @default.
- W3089578413 hasLocation W30895784132 @default.
- W3089578413 hasLocation W30895784133 @default.
- W3089578413 hasOpenAccess W3089578413 @default.
- W3089578413 hasPrimaryLocation W30895784131 @default.
- W3089578413 hasRelatedWork W3012336022 @default.
- W3089578413 hasRelatedWork W3040137343 @default.
- W3089578413 hasRelatedWork W3045573749 @default.
- W3089578413 hasRelatedWork W3046519041 @default.
- W3089578413 hasRelatedWork W3046807162 @default.
- W3089578413 hasRelatedWork W3046884912 @default.
- W3089578413 hasRelatedWork W3048539433 @default.
- W3089578413 hasRelatedWork W3194513569 @default.
- W3089578413 hasRelatedWork W3208092296 @default.
- W3089578413 hasRelatedWork W4365462004 @default.
- W3089578413 hasVolume "27" @default.
- W3089578413 isParatext "false" @default.
- W3089578413 isRetracted "false" @default.
- W3089578413 magId "3089578413" @default.
- W3089578413 workType "article" @default.